PaxMedica, Inc. Statistics
Want to see PXMD full AI Analyst Report?
PaxMedica, Inc. (PXMD) Stock Statistics & Valuation Metrics
Total Valuation
PaxMedica, Inc. has a market cap or net worth of $88.39K. The enterprise value is -$4.62T.
- Market Cap
- $88.39K
- Enterprise Value
- -$4.62T
Share Statistics
PaxMedica, Inc. has 126,264,370 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 126,264,370
- Owned by Insiders
- ―
- Owned by Institutions
- 0.06%
Financial Efficiency
PaxMedica, Inc.’s return on equity (ROE) is -5.40 and return on invested capital (ROIC) is -415.56%.
- Return on Equity (ROE)
- -5.40
- Return on Assets (ROA)
- -3.22
- Return on Invested Capital (ROIC)
- -415.56%
- Return on Capital Employed (ROCE)
- -4.16
- Revenue Per Employee
- 0
- Profits Per Employee
- -3.05M
- Employee Count
- 6
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of PaxMedica, Inc. is -0.00. PaxMedica, Inc.’s PEG ratio is -0.00.
- PE Ratio
- -0.00
- PS Ratio
- 0.00
- PB Ratio
- 0.00
- Price to FCF
- -0.01
- Price to Operating Cash Flow
- -0.00
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, PaxMedica, Inc. had revenue of 0 and earned -18.29M in profits. Earnings per share was -11.00.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -16.14M
- Pretax Income
- -18.29M
- Net Income
- -18.29M
- EBITDA
- -16.14M
- Earnings Per Share (EPS)
- -11.00
Cash Flow
In the last 12 months, operating cash flow was -9.32M and capital expenditures 0, giving a free cash flow of -9.32M billion.
- Operating Cash Flow
- -9.32M
- Free Cash Flow
- -9.32M
- Free Cash Flow per Share
- -6.48
Dividends & Yields
PaxMedica, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -12183.63%
- Earnings Yield
- -1571170.86%
Stock Price Statistics
- Beta
- 65.56
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.07
- 200-Day Moving Average
- 0.08
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
PaxMedica, Inc. upcoming earnings date is ―, TBA (Not Confirmed).
- Last Earnings Date
- Nov 13, 2024
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
PaxMedica, Inc. as a current ratio of 3.16, with Debt / Equity ratio of 0.00%
- Current Ratio
- 3.16
- Quick Ratio
- 3.16
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.29
- Interest Coverage Ratio
- -1761.59
Taxes
In the past 12 months, PaxMedica, Inc. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
PaxMedica, Inc. EV to EBITDA ratio is 0.29, with an EV/FCF ratio of 0.43.
- EV to Sales
- 0.00
- EV to EBITDA
- 0.29
- EV to Free Cash Flow
- 0.43
- EV to Operating Cash Flow
- 0.43
Balance Sheet
PaxMedica, Inc. has $324.49K in cash and marketable securities with $0.00 in debt, giving a net cash position of $324.49K billion.
- Cash & Marketable Securities
- $324.49K
- Total Debt
- $0.00
- Net Cash
- $324.49K
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- -$0.24
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Scores
- Smart Score
- ―
- AI Score
- 32

